DR. RAMAKRISHNA BATTINI M.D. NPI 1710122601

NPI Details

DR. Ramakrishna Battini, M.D. is a hematology and oncology internal medicine in Germantown, TN with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Ramakrishna Battini, M.D. NPI is 1710122601. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7945 WOLF RIVER BLVD
GERMANTOWN, TN
ZIP 38138
Phone: (901) 683-0055
Fax: (901) 685-2969

The NPI 1710122601 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Nephelometry, test method using light (HCPCS:83883)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood creatinine level (HCPCS:82565)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Uric acid level, blood (HCPCS:84550)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Magnesium level (HCPCS:83735)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Unclassified drugs (HCPCS:J3490)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Red blood count, automated test (HCPCS:85045)
• Blood test, clotting time (HCPCS:85610)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Folic acid level, serum (HCPCS:82746)
• Blood glucose (sugar) level (HCPCS:82947)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Rheumatoid factor level (HCPCS:86431)
• Therapy procedure using functional activities (HCPCS:97530)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Training for self-care or home management, each 15 minutes (HCPCS:97535)
• Injection, fentanyl citrate, 0.1 mg (HCPCS:J3010)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)

The enumeration date for this NPI number is 12/8/2008 and was last updated on 9/12/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: